These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10549506

  • 1. Primary CNS lymphoma: chemotherapy followed by radiotherapy or chemotherapy alone? A randomized multicentric study.
    Thiel E, Korfel A, Hinkelbein W.
    Front Radiat Ther Oncol; 1999; 33():349-53. PubMed ID: 10549506
    [No Abstract] [Full Text] [Related]

  • 2. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R, Tanaka R.
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [Abstract] [Full Text] [Related]

  • 3. Treatment of primary central nervous system lymphoma: still more questions than answers.
    Fine HA.
    Blood; 1995 Oct 15; 86(8):2873-5. PubMed ID: 7579377
    [No Abstract] [Full Text] [Related]

  • 4. Primary central nervous system lymphoma: curable without toxicity?
    DeAngelis LM.
    Cancer J Sci Am; 1996 Oct 15; 2(3):137-9. PubMed ID: 9166513
    [No Abstract] [Full Text] [Related]

  • 5. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 6. Primary CNS lymphoma.
    Gerstner E, Batchelor T.
    Expert Rev Anticancer Ther; 2007 May 01; 7(5):689-700. PubMed ID: 17492932
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 8. Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
    Alnahhas I, Malkin M.
    Neurology; 2015 Dec 15; 85(24):e187-9. PubMed ID: 26668244
    [No Abstract] [Full Text] [Related]

  • 9. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
    Korfel A, Thiel E.
    Leuk Lymphoma; 1998 Aug 15; 30(5-6):609-17. PubMed ID: 9711923
    [Abstract] [Full Text] [Related]

  • 10. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy.
    DeAngelis LM.
    J Neurooncol; 1999 Jul 15; 43(3):249-57. PubMed ID: 10563431
    [Abstract] [Full Text] [Related]

  • 11. Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy.
    Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, Khanna N, Dasgupta A, Kakoti S, Chatarjee A, Jain H, Epari S, Laskar S, Sengar M, Gupta T.
    Br J Haematol; 2023 Apr 15; 201(1):150-153. PubMed ID: 36682363
    [No Abstract] [Full Text] [Related]

  • 12. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
    Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F, International Extranodal Lymphoma Study Group (IELSG).
    Lancet; 2009 Oct 31; 374(9700):1512-20. PubMed ID: 19767089
    [Abstract] [Full Text] [Related]

  • 13. CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.
    Bessell EM, Graus F, López-Guillermo A, Villá S, Verger E, Petit J, Holland I, Byrne P.
    Int J Radiat Oncol Biol Phys; 2001 Jun 01; 50(2):457-64. PubMed ID: 11380234
    [Abstract] [Full Text] [Related]

  • 14. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results.
    Cher L, Glass J, Harsh GR, Hochberg FH.
    Neurology; 1996 Jun 01; 46(6):1757-9. PubMed ID: 8649588
    [Abstract] [Full Text] [Related]

  • 15. MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas.
    Ferreri AJ, Dell'Oro S, Foppoli M, Bernardi M, Brandes AA, Tosoni A, Montanari M, Balzarotti M, Spina M, Ilariucci F, Zaja F, Stelitano C, Bobbio F, Corazzelli G, Baldini L, Ponzoni M, Picozzi P, Caligaris Cappio F, Reni M.
    Neurology; 2006 May 09; 66(9):1435-8. PubMed ID: 16682682
    [Abstract] [Full Text] [Related]

  • 16. Treatment of patients with high grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy?
    Magrath IT, Haddy TB, Adde MA.
    Leuk Lymphoma; 1996 Mar 09; 21(1-2):99-105. PubMed ID: 8907276
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy is effective as early treatment for primary central nervous system lymphoma.
    Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A.
    J Neurol; 1999 Jan 09; 246(1):31-7. PubMed ID: 9987711
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.